It will be results only, no deal with a pharmaceutical company yet definitely no projected sales as that's years away. But it is confidence enough to say this is a treatment that works in human testing, it's relatively safe. That is a rerate of orders of magnitude. We have hit company values of 500 million plus before in early stages, I'm not being so brave (or foolish) as some to say a market cap of 100 billion, but anything over previous high water mark is likely. 50c+, my concern is delays with weeks becoming months September to late 2023 to some time in the new year, news release is the unpredictable element though it is inevitable, but if it's not January I am becoming more cautious.
BIT Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held
